Latest filing published 22 Mar 2022 for Immuneering Corp, €6,115.
Filing timeline
BuySaleInsider track record
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Scott Barrett: trading record in brief
Scott Barrett, listed as senior executive, appears in our data through filings on Immuneering Corp shares, published by SEC (Form 4). Over a trading history stretching from 3 August 2021 to 22 March 2022, the count stands at 3 filings.
No open-market sale appears; the market trades are 2 purchases worth €15k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2022: 1 purchase and no sales on the market.
The newest entry dates from 22 March 2022: an open-market purchase of €6,115, in Immuneering Corp. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Scott Barrett
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 900 shares@ US$7.485100.0% of flowClass A Common StockSEC:0001415889-22-003270:0Canonical exit: 20 Jun 2022 (T+90)
- 5,996 sharesClass A Common StockSEC:0001104659-21-099725:0
2 of 2 declarations
